Episode Details
Back to Episodes
Genetic Diagnostics and the Rise of Student CEOs | Dr. Jonathan Hill
Description
Could future physicians combine a patient’s genome with artificial intelligence to make faster, more precise diagnoses?
Dr. Jonathon Hill returns to BioTalk Unzipped to discuss the convergence of genetics, AI, diagnostics, entrepreneurship, higher education, and biotechnology.
Jonathon explains an unusual partnership between academia and industry that allows students to build projects with genuine commercial potential, sometimes moving from student researcher to company founder at an exceptionally young age.
The conversation then explores how AI could influence genomic medicine and future diagnosis. Jonathon challenges the traditional trial-and-error model of medicine and considers what could become possible as genetic information and computational tools improve.
In New News, the group discusses Lumicell’s fluorescence-guided technology for identifying residual breast-cancer tissue during surgery and what improved visualization could mean for patients.
Jonathon also offers advice to students interested in genetics and biotechnology, emphasizing laboratory experience, curiosity, and a willingness to take intelligent risks.
The episode closes with a candid look at the regulatory hurdles facing biotechnology companies and a broader question confronting higher education: how can universities give students enough real-world value to justify the growing cost of a degree?
Chapters
01:01 - Balancing life as a professor while running a laboratory
02:00 - The unique partnership between university and industry
03:55 - Why more students are pursuing entrepreneurship after college
06:31 - How AI may affect genetics research, biotechnology, and future diagnosis
12:58 - New News: Lumicell’s breakthrough in residual breast-cancer imaging
16:10 - Dr. Hill’s passions inside and outside his professional life
17:37 - Advice for young scientists and aspiring biotechnology entrepreneurs
21:00 - Bioinnovation, scientific business training, and concerns about the cost of higher education
28:48 - Regulatory hurdles and progress for Wasatch and its DNA research
Connect with Dr. Jonathon Hill
Dr. Jonathon Hill
https://www.linkedin.com/in/jonathon-t-hill/
Wasatch Labs
https://www.wasatchbiolabs.com/
Rainforest Trust
https://www.rainforesttrust.org/
Connect with the hosts
Dr. Chad Briscoe
https://www.linkedin.com/in/chadbriscoe/
Gregory Austin
https://www.linkedin.com/in/gregoryaustin1/
New News
FDA approval of Lumicell’s fluorescent system for highlighting residual breast cancer:
Image credits
Gattaca: https://www.justwatch.com/us/movie/gattaca
La